Rhine bio's response to the bio industry plan did not have any impact on the company
-
Last Update: 2010-06-14
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Rhine biology announced a share price change on the 11th According to the company, there are no major events that should be disclosed but not disclosed, and the operation is normal In addition, the company makes explanations for media reports Recently, it has been reported that during the "China Biotechnology and Industrial Development Forum", leaders of the Ministry of health and the CPPCC National Committee and other relevant ministries and commissions disclosed that the 12th Five Year Plan for the development of the biological industry led by the national development and Reform Commission will be submitted to the State Council in June The company said that it would pay close attention to the trend of relevant policies, and at present, the incident has not brought any impact on the company's operation The company's main business is the production and sales of plant extracts, and plant extraction is a subdivision industry of the biological industry The impact of the relevant policies formulated in the 12th Five Year Plan for the development of the biological industry on the plant extraction industry cannot be determined at present.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
